Association of
+7 (495) 933-7040

Larisa Matveeva appointed the Executive Director of the Association of International Pharmaceutical Manufacturers


March 14, 2024, Moscow – the Association of International Pharmaceutical Manufacturers (AIPM) announces the appointment of Larisa Matveeva as the Executive Director of AIPM. The decision to this effect was made at the Extraordinary General Meeting of the Association member companies, held on March 13, 2024.

Larisa Matveeva is a highly qualified pharmaceutical industry professional with over 20 years of experience in managing key functions and businesses in international corporations and is also an expert in liaising with the government bodies and public organizations.

Before joining the Association, Mrs. Matveeva held the position of Vice President for Government Relations, Legal Affairs, and Ethics at the NIZHFARM Group (formerly STADA). Simultaneously, Larisa acted as the General Director of Nizhpharm JSC during 2022–2023. Throughout her career, she has occupied various roles, including regional ones, in international companies across different sectors — Novartis, Honeywell, Hewlett-Packard.

Mrs. Matveeva's primary expertise lies in providing legal support at all stages of pharmaceuticals circulation, the functioning of healthcare systems in the Russian Federation and EAEU markets, as well as dealing with intellectual property rights protection issues and business ethics.

Larisa Matveeva holds a law degree. She is a graduate of Kutafin Moscow State Law University (MSAL) and Lomonosov Moscow State University, Psychology Department.

"First of all, I would like to express my gratitude to the AIPM Board of Directors and the Association member companies for the immense trust they have placed in me. It is a great honor for me to represent the interests of the international industry, uphold its values and strategic priorities at this new stage of the Association's evolution. I am stepping into this role ready to work for the welfare of patients and the healthcare system, fostering open dialogue and partnership with all interested parties," states Larisa Matveeva.

"I am thrilled to welcome Larisa Matveeva's appointment as the Executive Director of AIPM. The process of finding a new leader was meticulous and transparent, and I am glad that she brings significant expertise in key areas of AIPM's focus to the Association. The refreshed leadership team of AIPM will continue to work for the benefit of patients in Russia, partnering with all stakeholders, while maintaining, as we did in the past 30 years, high standards and consistently ethical approaches to work," says Katerina Pogodina, Chair of the AIPM Board of Directors, Managing Director of Janssen, Russia and CIS pharmaceutical division of Johnson & Johnson.

"This appointment marks a new and significant phase in the Association's development. Over many years of successful operation, AIPM has achieved great results. With the new leadership, we have even more ahead of us, and I am confident that together with our dedicated colleagues and true professionals, we will achieve remarkable new goals, adhering to our shared and constant priorities — patient care and advancement of the pharmaceutical industry," highlights Nikita Ivanov, Vice Chairman of the AIPM Board of Directors, General Manager Pfizer Russia and Belarus.

Mrs. Matveeva takes over her position as the Executive Director of the Association on March 14, 2024. She succeeds Vladimir Shipkov, who had been leading the Association since 2007.



The Association of International Pharmaceutical Manufacturers (AIPM) was established in 1994 and represents in the Russian Federation the leading international pharmaceutical companies - producers and developers of modern effective, safe and high-quality medicines. Today, AIPM unites 56 international companies that provide over 80% of the world’s pharmaceutical products and over 60% of medicines imported to the Russian Federation.

For additional information, please contact:

Elena Yankovskaya, PR & Communications Director, AIPM
+7 (495) 933 70 40,